Cubist Systematic Strategies’s Vaxcyte PCVX Stock Holding History

Cubist Systematic Strategies’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.62M	Buy	+100,561	New	+$3.33M	0.02%	1187
2025 Q2	–	Sell	-5,800	Closed	-$219K	–	3385
2025 Q1	$219K	Buy	+5,800	New	+$464K	﹤0.01%	2487
2023 Q2	–	Sell	-30,308	Closed	-$1.14M	–	4104
2023 Q1	$1.14M	Sell	30,308 -118,812	-80%	-$5.04M	0.01%	2086
2022 Q4	$7.15M	Buy	149,120 +117,905	+378%	+$4.63M	0.04%	724
2022 Q3	$749K	Buy	31,215 +19,752	+172%	+$501K	﹤0.01%	2861
2022 Q2	$249K	Buy	+11,463	New	+$265K	﹤0.01%	3560
2021 Q1	–	Sell	-9,768	Closed	-$260K	–	2942
2020 Q4	$260K	Buy	+9,768	New	+$363K	﹤0.01%	2108

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Cubist Systematic Strategies's PCVX Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Vaxcyte (PCVX) in Q3 2025: 100,561 shares worth $3.62M. The stake represents 0.02% of the portfolio and ranks #1187 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in PCVX as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in PCVX in Q4 2020 and has held it in 7 quarters since. The position peaked at $7.15M in Q4 2022. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

Cubist Systematic Strategies held 100,561 shares of Vaxcyte worth $3.62M as of Q3 2025.
Vaxcyte was a new Cubist Systematic Strategies position in Q3 2025.
Vaxcyte made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1187 holding.
Cubist Systematic Strategies first reported a position in Vaxcyte in Q4 2020 and has held it in 7 quarters since.
Cubist Systematic Strategies's Vaxcyte position peaked at $7.15M in Q4 2022.
285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.